Premium Nahrungsergänzungsmittel | artgerecht

Congenital Dermal Melanocytosis – Causes and Treatment

Congenital dermal melanocytosis is a benign, birthmark condition in which melanocytes remain in the deep skin layer, causing bluish-grey patches visible at birth.

Regular tips about health Regular tips about health

Things worth knowing about "Congenital Dermal Melanocytosis"

Congenital dermal melanocytosis is a benign, birthmark condition in which melanocytes remain in the deep skin layer, causing bluish-grey patches visible at birth.

What is Congenital Dermal Melanocytosis?

Congenital dermal melanocytosis (formerly known as Mongolian spot) is a benign, congenital pigmentation condition of the skin. It occurs when pigment-producing cells called melanocytes fail to fully migrate from the deep dermis to the outer epidermis during embryonic development, and instead remain within the dermis. This results in characteristic bluish-grey or greyish-green skin patches that are typically present at birth.

Causes

The condition arises from a migration disorder of melanocytes during embryonic development. Normally, melanocytes migrate from the neural crest to the epidermis. When some of these cells remain in the dermis, they produce the typical bluish discolouration because deeply situated melanin reflects light differently -- a phenomenon known as the Tyndall effect.

Genetic predisposition plays a significant role.
The condition is more prevalent in individuals with darker skin tones, particularly those of Asian, African, Hispanic, and Southern European descent.
It is considered an anatomical variant rather than a disease in the traditional sense.

Symptoms and Appearance

Congenital dermal melanocytosis is characterised by the following features:

Flat, bluish-grey, greyish-green, or slate-coloured skin patches
Patches may have sharp or diffuse borders and vary in size
Most commonly located over the sacral and lumbar regions; less commonly on the shoulders, arms, or other body areas
No pain, itching, or signs of inflammation
Patches typically fade spontaneously by school age (around 5 to 7 years); in rare cases they may persist into adulthood

Diagnosis

The diagnosis of congenital dermal melanocytosis is generally made clinically, based on the characteristic appearance of the skin. Further investigations are not required in typical cases.

Dermoscopy: Magnified examination of the skin lesion can aid in differentiation from other conditions.
Biopsy: Only necessary in atypical cases to exclude other pigmented lesions such as blue naevus or melanoma.
Differential diagnosis: It is clinically important to distinguish the condition from bruising (haematomas), blue naevi, and other melanocytoses -- particularly to rule out non-accidental injury in children.

Treatment

Since congenital dermal melanocytosis is a benign, self-limiting condition, treatment is not required in most cases.

The patches resolve spontaneously in the majority of affected children before or during early school years.
In cases where patches persist into adulthood and are considered cosmetically bothersome, laser treatment (e.g. Q-switched Nd:YAG laser) may be considered.
Regular dermatological follow-up is advisable for extensive or atypical presentations.

Special Considerations and Clinical Relevance

Congenital dermal melanocytosis is generally of no medical concern and requires no treatment. However, it is clinically important to distinguish these bluish patches from bruises, as they can occasionally be misinterpreted by inexperienced observers as signs of child abuse. Proper documentation at birth is therefore recommended. In very rare cases, extensive congenital dermal melanocytosis may be associated with certain storage disorders (e.g. GM1 gangliosidosis), which may warrant further diagnostic evaluation.

References

Happle R. - Mosaicism in Human Skin. Springer, Berlin Heidelberg, 2014.
Kanada KN, Merin MR, Munden A, Friedlander SF. - A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. Journal of Pediatrics, 2012; 161(2): 240-245.
World Health Organization (WHO) - ICD-11: Congenital dermal melanocytosis (2E70.0). https://icd.who.int/

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.